Azpire Pharma Private Limited
About Azpire Pharma Private Limited
Data last updated:
Azpire Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2019PTC327162. Its GSTIN is 27AASCA4341B1ZU (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Riddhi Sahil Javeri and Sahil Sagar Javeri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 3 Floor – G A Todi Industrial Estate Sitaram Jadhav Marg Sun Mill Compound, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.8 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.39 Cr (net margin 29.1%) and EBITDA of ₹1.97 Cr (EBITDA margin 41.1%). Revenue has grown at a compounded annual rate (CAGR) of 53% over three years and 25% over five years.
Company details
Contact details
Azpire Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 3 Floor – G A Todi Industrial Estate Sitaram Jadhav Marg Sun Mill Compound, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Azpire Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Azpire Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Azpire Pharma Private Limited, buy the company report.
Financials of Azpire Pharma Private Limited
FY 2025 filings availableAzpire Pharma Private Limited reported revenue of ₹4.8 Cr (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 28% growth in the latest year. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.39 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.1% | ||||
| Net Profit Margin | 29.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Azpire Pharma Private Limited, buy the company report.
Board of directors of Azpire Pharma Private Limited
Azpire Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Riddhi Sahil Javeri Also directs: Unihealth Hospitals Limited, Intermed Life Sciences Private Limited, Intermed Laboratories Private Limited and 1 more | Director | 24 Jun 2019 | 7 Years 4 Months | Current |
| Sahil Sagar Javeri Also directs: Quntrol Laboratories Private Limited | Director | 24 Jun 2019 | 7 Years 4 Months | Current |
Auditor
Azpire Pharma Private Limited is audited by Harish Choudhary & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Harish Choudhary & Associates | FY 2023 | 157026 |
Shareholding
The shareholding of Azpire Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Azpire Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Azpire Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Azpire Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Azpire Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AASCA4341B1ZU | Maharashtra | Active | 02 Jul 2019 |
| 33AASCA4341B1Z1 | Tamil Nadu | Active | 19 Sep 2019 |
To see the full GST registrations and return filing status of Azpire Pharma Private Limited, buy the company report.
Recent activity
Azpire Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Riddhi Sahil Javeri was appointed as Director on 24 Jun 2019.
Frequently asked questions
Azpire Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 June 2019 (7+ years old) and is registered under CIN U24299MH2019PTC327162.
Azpire Pharma has 2 current directors:
- Riddhi Sahil Javeri - Director
- Sahil Sagar Javeri - Director
The latest financial statements of Azpire Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Azpire Pharma is 27AASCA4341B1ZU, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AASCA4341B1Z1 (Tamil Nadu).
The CIN (Corporate Identification Number) of Azpire Pharma is U24299MH2019PTC327162. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Azpire Pharma was incorporated on 24 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Riddhi Sahil Javeri was appointed as Director on 24 Jun 2019. Sahil Sagar Javeri was appointed as Director on 24 Jun 2019.
The registered office of Azpire Pharma is at A – 3 Floor – G A Todi Industrial Estate Sitaram Jadhav Marg Sun Mill Compound, Mumbai, Maharashtra, India – 400013.
Azpire Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Azpire Pharma can be reached at its registered office: A – 3 Floor – G A Todi Industrial Estate Sitaram Jadhav Marg Sun Mill Compound, Mumbai, Maharashtra, India – 400013.